Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.
A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.
Top Santé on MSN
PSA et prostate : à partir de quel âge faut-il envisager ce dépistage, et pourquoi ?
Fréquent mais longtemps silencieux, le cancer de la prostate interroge les hommes dès la cinquantaine. À quel âge parler du ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...
Pour certains hommes atteints d’un cancer de la prostate, le parcours de soins pourrait bientôt être considérablement allégé. Une nouvelle forme de radiothérapie, déjà déployée au Royaume-Uni, permett ...
Le cancer de la prostate est un des cancers les plus fréquents chez les hommes, avec une majorité diagnostiqués ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results